Rimidi
Rimidi is an Atlanta-based digital health company offering an EHR-integrated clinical management platform for remote patient monitoring and chronic disease management, aggregating patient-generated device data with EHR clinical data to serve hospitals, physician practices, FQHCs, and value-based care organizations across North America.
- Company typePrivate
- Founded2012
- HeadquartersAtlanta, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Rimidi does
Rimidi is an Atlanta-based digital health company founded in 2012 by Dr. Lucienne Ide (MD, PhD) that provides an EHR-integrated clinical management platform for remote patient monitoring (RPM) and chronic disease management, with a primary focus on cardiometabolic conditions including diabetes, cardiovascular disease, heart failure, chronic kidney disease, fatty liver disease, and respiratory conditions. The platform's core technical architecture combines patient-generated health data from connected medical devices — including continuous glucose monitors from Dexcom, Abbott FreeStyle Libre, and Senseonics Eversense; cellular-enabled blood pressure cuffs; digital scales; pulse oximeters; and digital inhalers — with clinical data from electronic health records via SMART on FHIR and API-based integrations into Epic, Oracle Cerner, athenahealth, eClinicalWorks, NextGen, MEDITECH, OCHIN, and Veradigm. Embedded Clinical Decision Support cards surface guideline-based, patient-specific actions inside clinicians' existing EHR workflows, with documented outcomes including a 2.8% average reduction in A1c among high-risk type 2 diabetes patients and 95% of enrolled hypertension patients achieving blood pressure below 140/90 within 20 weeks.
Rimidi's product surface spans five software programs (RPM, Chronic Care Management, Remote Therapeutic Monitoring, Behavioral Health Integration, and Continuous Glucose Monitoring insights), eight condition-specific clinical modules, a portfolio of cellular- and Bluetooth-enabled connected devices, and professional services covering clinical monitoring (delivered by a US-based nursing team), EHR integration, onboarding, device management, and billing support. Monetization is built on a subscription SaaS platform fee with optional recurring services revenue from outsourced clinical monitoring, hardware sales from connected devices, and reimbursement facilitation tied to RPM (CPT 99453/99454/99457/99458) and CCM (CPT 99490/99439/99487/99489) codes.
The company targets hospitals and health systems, physician practices, federally qualified health centers (FQHCs) and rural health clinics, value-based care organizations (ACOs, MCOs, capitated providers), pharmaceutical companies, and medical device manufacturers — with named customers including Emory Healthcare, Boston Medical Center, Endeavor Health, Leon Medical Centers, Desert Oasis Healthcare, Brevard Health Alliance, and TrueCare. Distribution is enterprise field sales-led with a "Request Demo" motion and an indirect layer through the Rimidi Care Network (GatewayMD, Quest Health). In March 2026, Rimidi was acquired by Health Recovery Solutions (HRS), with Dr. Ide transitioning to Chief Medical Officer of HRS to integrate the platforms throughout 2026.
Rimidi firmographics
Firmographics- Name
- Rimidi
- Legal name
- Rimidi, Inc.
- Website
- https://rimidi.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Acquired
- Headcount range
- 1–10 employees
- Short description
- Rimidi is an Atlanta-based digital health company offering an EHR-integrated clinical management platform for remote patient monitoring and chronic disease management, aggregating patient-generated device data with EHR clinical data to serve hospitals, physician practices, FQHCs, and value-based care organizations across North America.
- Ownership category
- akta.pro rank
Rimidi industry classification
Industry- Product category
- Remote Patient Monitoring Software
- NAICS
- Offices of Physicians (6211), Services for the Elderly and Persons with Disabilities (62412)
- SIC
- Services-Home Health Care Services (8082), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity) (HLALAFAA)
- akta.pro secondary industries
- Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management) (HLALAFAL), Chronic Disease RPM Platforms (Diabetes/HTN/COPD/CHF) (HLACAFAA), Patient App, Adherence & Engagement for RPM Programs (HLACAFAJ), Medication Adherence, Digital Therapeutics & Remote Coaching (condition-specific programs) (HLALAFAF), RPM Reimbursement, Billing & Program Operations Platforms (HLACAFAN)
Keywords
Where Rimidi is headquartered
LocationHeadquarters
- HQ city
- Atlanta
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Rimidi business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain, Infrastructure
Revenue model
- Software Platform Subscription: SaaS-based clinical management platform providing EHR-integrated RPM and CCM software capabilities. Revenue derived from platform licensing fees for healthcare organizations.
- Clinical Monitoring Services: Outsourced clinical monitoring services where Rimidi's US-based nursing team monitors patients for healthcare organizations. Reduces burden on provider practices.
- Connected Devices: Portfolio of integrated connected medical devices including blood glucose monitors, CGMs, blood pressure cuffs, digital scales, pulse oximeters, and digital inhalers with flexible ordering and shipping options.
- Healthcare Reimbursement Facilitation: Platform enables healthcare providers to bill Medicare/Medicaid for RPM (CPT codes 99453, 99454, 99457, 99458) and CCM (CPT codes 99490, 99439, 99487, 99489) services, with billing support and monthly reports. Rimidi benefits from provider adoption and program expansion.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Enterprise Healthcare Organizations |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Rimidi product offering
Product offeringCore offering
Rimidi sells an EHR-integrated clinical management software platform that enables healthcare providers to deliver Remote Patient Monitoring (RPM), Chronic Care Management (CCM), Remote Therapeutic Monitoring (RTM), Behavioral Health Integration (BHI), and Population Health programs for cardiometabolic chronic conditions. The platform combines patient-generated health data from connected medical devices (CGMs, blood glucose monitors, blood pressure cuffs, scales, pulse oximeters, digital inhalers) with clinical data from EHR systems via SMART on FHIR integrations, and embeds clinical decision support cards to drive proactive, guideline-based care.
Product overview
Rimidi is a digital health company offering an EHR-integrated clinical management platform for remote patient monitoring (RPM) and chronic disease management. The platform operates as a modular system combining: (1) Software programs including Remote Patient Monitoring, Chronic Care Management, Population Health Initiatives, Remote Therapeutic Monitoring, Behavioral Health Integration, and Continuous Glucose Monitoring; (2) Connected devices including Blood Glucose Monitors, CGMs (Dexcom, Libre, Eversense), Blood Pressure Cuffs, Digital Scales, Pulse Oximeters, and Digital Inhalers; (3) Clinical services including Monitoring, EHR Integration, Onboarding, Device Management, and Billing Support; and (4) Clinical modules for specific conditions including Diabetes, Cardiovascular Disease, Heart Failure, Weight Management, Chronic Kidney Disease, Fatty Liver Disease, Respiratory, and Maternal Health. The platform integrates with major EHR systems (Epic, Oracle Cerner, athenahealth, Meditech, Veradigm, eClinicalWorks, NextGen, Ochin) via SMART on FHIR and aggregates data from connected medical devices directly into clinical workflows. The company was acquired by Health Recovery Solutions (HRS) in March 2026.
Differentiator
Problem solved
Functional benefit
Products and services
- Remote Patient Monitoring (RPM) Software
Quantifiable outcome
- 2.8% average reduction in A1c levels in high-risk type 2 diabetes patients
- +4 more outcomes
Companies that use Rimidi
Customer profileNamed customers14 records
Segments7 records
Ideal customer profiles4 records
Rimidi technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration12 records
AI capability1 record
Feature5 records
Rimidi partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Health Recovery Solutions (HRS)coreStrategic acquisition of Rimidi by Health Recovery Solutions (HRS), a leading remote patient monitoring and enterprise remote patient care platform. The acquisition combines Rimidi's expertise in continuous glucose monitoring, EHR integration, and ambulatory disease management with HRS's post-acute care infrastructure. Rimidi's CEO and Founder, Dr. Lucienne Ide, became HRS's Chief Medical Officer following the acquisition. Integration will continue throughout 2026, bringing together capabilities, services, and support into a unified experience.
- Brevard Health AlliancecorePartnership with Brevard Health Alliance (BHA), a federally qualified health center in Florida serving approximately 65,000 patients across 16 sites, to implement an RPM program for hypertension management. The program was launched with support from a State of Florida Cinotti Grant and demonstrated significant clinical success with 95% of enrolled patients achieving BP control and nearly 200 patients enrolled in 20 weeks.
- Rimidi Care Network PartnerscoreCare management partners including GatewayMD and Quest Health provide clinical and operational services for RPM, CCM, APCM, RTM, BHI programs and value-based population health initiatives using the Rimidi platform. Partners communicate with patients and care teams to support chronic disease management.
- DexcomcoreIntegration partnership for Continuous Glucose Monitoring data aggregation. Rimidi aggregates data from Dexcom CGM devices, providing clinicians comprehensive glucose insights directly within EHR workflows for diabetes population management.
- Abbott (FreeStyle Libre)coreIntegration partnership for Continuous Glucose Monitoring data aggregation. Rimidi integrates with Abbott's FreeStyle Libre CGM devices, enabling glucose data to flow into EHR workflows alongside clinical information.
- Senseonics (Eversense)coreIntegration partnership for Continuous Glucose Monitoring data aggregation. Rimidi integrates with the implantable Eversense CGM from Senseonics, bringing data from this device into the EHR-integrated platform.
- Henry ScheinminorHenry Schein representative connected Brevard Health Alliance with Rimidi, recognizing strong fit between Rimidi's capabilities and BHA's population health goals, enabling BHA to secure funding and quickly implement RPM rollout.
Scale indicators5 records
Recent moves7 records
Expansion highlights6 records
Rimidi competitors and assessment
Company assessmentDirect peers
- Vivify Health: One of the most established RPM/CCM platform providers, offering device-agnostic remote monitoring programs to health systems, payers, and providers. Directly comparable to Rimidi in target customers, program types (RPM/CCM), and integration-led GTM, though Vivify skews larger and more enterprise-focused.
- CareSimple: EHR-integrated RPM and chronic care management platform that targets hospitals, physician practices, and post-acute providers with cellular-connected devices and a clinical workflow layer. Closely comparable to Rimidi across platform structure, customer segments, and remote monitoring program economics.
- Validic: Digital health data platform that connects patient-generated health data from hundreds of devices into EHRs and analytics systems for RPM and population health use cases. Comparable as a device-agnostic, EHR-integrated data layer competing for similar health system and chronic disease workflows.
- Omada Health: Virtual-first chronic disease management company covering diabetes, hypertension, and obesity prevention/treatment for payers and employers. Comparable in chronic disease focus and outcome-driven value proposition, though Omada is more consumer/employer-led while Rimidi is provider-led.
- Health Recovery Solutions (HRS): Enterprise remote patient care platform and Rimidi's acquirer; HRS historically focused on post-acute RPM (skilled nursing, home health) before extending into longitudinal care via the Rimidi deal. Pre-acquisition, HRS was a direct peer competing for similar provider RPM contracts.
- 100Plus: Remote patient monitoring provider offering cellular-connected devices, clinician dashboards, and EHR integration for primary care practices managing hypertension, diabetes, and other chronic conditions. Comparable in target customer (physician practices), device-driven approach, and chronic disease programs.
Broad incumbents
- Philips Remote Patient Monitoring: Broad incumbent offering enterprise RPM, telehealth, and population health solutions across acute, post-acute, and ambulatory settings as part of a much larger health technology portfolio. Overlaps with Rimidi on hospital-system RPM but operates at significantly larger scale and with proprietary device/hardware integration.
- Teladoc Health / Livongo: Major virtual care platform that absorbed Livongo's diabetes and chronic condition management capabilities. Overlaps with Rimidi in diabetes and cardiometabolic care, but operates at vastly greater scale through payer, employer, and provider channels rather than a focused EHR-native workflow.
Emerging players
- WellDoc: Digital therapeutic company focused on cardiometabolic conditions (notably diabetes) with FDA-cleared software products. Comparable in chronic disease focus and clinical evidence emphasis, though WellDoc leans more toward a regulated digital therapeutic than an EHR-integrated RPM platform.
- ResMed (including Propeller Health): Respiratory and connected health company that, through Propeller Health, offers digital inhaler and COPD/asthma monitoring — overlapping with Rimidi's respiratory module and Adherium integration. Comparable in the digital-inhaler/RTM niche but not a full multi-condition RPM platform.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Rimidi social profiles
Digital presenceRimidi compliance and trust
Trust signalCompliance4 records
Rimidi financial estimates
Financial estimateRevenue estimate
Valuation estimate
Rimidi leadership team
Management profileNumber of profiles
Profiles5 records
Rimidi funding detail
Funding detailFunding overview
Funding rounds4 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Rimidi M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Rimidi
What does Rimidi do?
Rimidi sells an EHR-integrated clinical management software platform that enables healthcare providers to deliver Remote Patient Monitoring (RPM), Chronic Care Management (CCM), Remote Therapeutic Monitoring (RTM), Behavioral Health Integration (BHI), and Population Health programs for cardiometabolic chronic conditions. The platform combines patient-generated health data from connected medical devices (CGMs, blood glucose monitors, blood pressure cuffs, scales, pulse oximeters, digital inhalers) with clinical data from EHR systems via SMART on FHIR integrations, and embeds clinical decision support cards to drive proactive, guideline-based care.
Is Rimidi a public or private company?
Rimidi is a private company. It is classified as corporate owned and is currently acquired.
When was Rimidi founded?
Rimidi was founded in 2012. It employs 1 to 10 people.
Where is Rimidi based?
Rimidi is headquartered in Atlanta, United States, in the North America region.
How does Rimidi make money?
Four revenue lines are on record. Software Platform Subscription is the primary driver. The others are clinical Monitoring Services, connected Devices and healthcare Reimbursement Facilitation.
Who are Rimidi's main competitors?
Direct peers on record are Vivify Health, CareSimple, Validic, Omada Health, Health Recovery Solutions (HRS) and 100Plus. Broad incumbents are Philips Remote Patient Monitoring and Teladoc Health / Livongo. Emerging players are WellDoc and ResMed (including Propeller Health).
Does Rimidi have an API?
No public API is recorded for Rimidi.
What industry is Rimidi in?
Rimidi's product category is Remote Patient Monitoring Software. Its primary akta.pro industry code is HLALAFAA, Cardiometabolic RPM & Chronic Disease Management (diabetes, hypertension, CHF, obesity), with a secondary code of HLALAFAL, Multi-Condition RPM Platforms & Care Orchestration (device-agnostic, population management). Its NAICS code is 6211 and its SIC code is 8082.